Skip to main content

Table 2 The laboratory data of participants

From: Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study

Laboratory data

Total

Disease severity

Death outcome

P-value

N = 873

Non-severe (N = 574)

Severe (N = 299)

P-value

No

(N = 751)

Yes

(N = 122)

Leukopenia < 3500/mm3

39 (4.5)

20 (3.5)

19 (6.4)

0.06

30 (4.0)

9 (7.4)

0.09

Leukocytosis > 11,000/mm3

167 (19.1)

108 (18.8)

59 (19.7)

0.79

135 (18)

32 (26.2)

0.03

Neutropenia < 1500/mm3

17 (1.9)

12 (2.1)

5 (1.7)

0.80

14 (1.9)

3 (2.5)

0.72

Neutrophilia > 8000/mm3

291 (33.3)

168 (29.3)

123 (41.1)

0.00

222 (29.6)

69 (56.6)

0.00

Lymphocytopenia < 1000/mm3

434 (49.7)

270 (47.0)

164 (54.8)

0.03

364 (48.5)

70 (57.4)

0.08

Lymphocytosis > 4000/mm3

17 (1.9)

11 (1.9)

6 (2.0)

1.00

15 (2.0)

2 (1.6)

1.00

Thrombocytopenia < 100,000/mm3

65 (7.4)

39 (6.8)

26 (8.7)

0.34

56 (7.5)

9 (7.4)

1.00

Thrombocytosis > 450,000/mm3

11 (1.3)

7 (1.2)

4 (1.3)

1.00

11 (1.5)

0 (0)

0.38

Elevated LDH > 245 U/liter

316 (36.2)

176 (30.7)

140 (46.8)

0.00

217 (28.9)

99 (81.1)

0.00

Elevated CRP > 10 mg/liter

542 (62.1)

339 (59.1)

203 (67.9)

0.01

433 (57.7)

109 (89.3)

0.00

Elevated Procalcitonin > 0.5 ng/ml

63 (7.2)

30 (5.2)

33 (11.0)

0.00

37 (4.9)

26 (21.3)

0.00

  1. Categorical variables are presented as numbers (percentages); LDH lactate dehydrogenase, CRP C-reactive protein